12
2002
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.

Nancy Kemeny , David Ilson , David Kelsen , Ellen Hollywood
Clinical Cancer Research 7 ( 12) 3963 -3970

21
2001
Liver-directed conversion therapy in metastatic colon cancer

Ghassan K. Abou-Alfa , Nancy Kemeny , Faek Jamali , Ali Shamseddine
Journal of gastrointestinal oncology 6 ( 3) 322 -328

1
2015
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease.

Bruce Minsky , Nancy E. Kemeny , David H. Ilson , David P. Kelsen
Annals of Surgical Oncology 9 ( 10) 954 -960

56
2002
CpG Island Hypermethylation in Human Colorectal Tumors Is Not Associated with DNA Methyltransferase Overexpression

Peter V. Danenberg , Cindy A. Eads , Kathleen D. Danenberg , Kazuyuki Kawakami
Cancer Research 59 ( 10) 2302 -2306

413
1999
Management of metastatic colorectal cancer.

Leonard B. Saltz
Oncology 28 ( 10) 841

2014
Irinotecan in the First-Line Treatment of Colorectal Cancer

Leonard B. Saltz
Oncology 12 ( 8) 54 -58

21
1998
Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments.

Mark J. Ratain , Allen S. Lichter , Ian F. Tannock , Leonard B. Saltz
Journal of Clinical Oncology 39 ( 9) 950 -955

1
2021
Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance)

Temidayo Fadelu , Sui Zhang , Donna Niedzwiecki , Xing Ye
Journal of Clinical Oncology 36 ( 11) 1112 -1120

26
2018
Frequency, characteristics, and correlates of pain in a pilot study of colorectal cancer survivors 1-10 years post-treatment.

Amy E. Lowery , Tatiana Starr , Lara K. Dhingra , Lauren Rogak
Pain Medicine 14 ( 11) 1673 -1680

15
2013
Capecitabine With Mitomycin Reduces Acute Hematologic Toxicity and Treatment Delays in Patients Undergoing Definitive Chemoradiation Using Intensity Modulated Radiation Therapy for Anal Cancer.

Karyn A. Goodman , Diana Julie , Andrea Cercek , Lajhem Cambridge
International Journal of Radiation Oncology Biology Physics 98 ( 5) 1087 -1095

23
2017
BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer.

Rona Yaeger , Andrea Cercek , Joanne F. Chou , Brooke E. Sylvester
Cancer 120 ( 15) 2316 -2324

118
2014
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies.

James Cassidy , Leonard B. Saltz , Bruce J. Giantonio , Fairooz F. Kabbinavar
Journal of Cancer Research and Clinical Oncology 136 ( 5) 737 -743

127
2010
Bevacizumab 5 mg/kg Can Be Infused Safely Over 10 Minutes

Diane L. Reidy , Ki Y. Chung , John P. Timoney , Vivian J. Park
Journal of Clinical Oncology 25 ( 19) 2691 -2695

47
2007
Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

Jeffrey A. Meyerhardt , Denise Heseltine , Donna Niedzwiecki , Donna Hollis
Journal of Clinical Oncology 24 ( 22) 3535 -3541

870
2006
Surgery and high-dose-rate intraoperative radiation therapy for recurrent squamous-cell carcinoma of the anal canal.

Jean L. Wright , Marc J. Gollub , Martin R. Weiser , Leonard B. Saltz
Diseases of The Colon & Rectum 54 ( 9) 1090 -1097

24
2011
FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation.

Jeannine A. Ruby , Tobias Leibold , Timothy J. Akhurst , Jinru Shia
Diseases of The Colon & Rectum 55 ( 4) 378 -386

21
2012